No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
CRSP241220P45000
- 2.35
- +1.10+88.00%
15min DelayClose Dec 13 15:59 ET
2.70High1.26Low
1.50Open1.25Pre Close250 Volume1.10K Open Interest45.00Strike Price59.67KTurnover58.79%IV2.58%PremiumDec 20, 2024Expiry Date1.22Intrinsic Value100Multiplier4DDays to Expiry1.13Extrinsic Value100Contract SizeAmericanOptions Type-0.6489Delta0.1303Gamma23.66Leverage Ratio-0.1205Theta-0.0034Rho-15.35Eff Leverage0.0180Vega
Intraday
- 5D
- Daily
News
3 Things You Need to Know If You Buy CRISPR Therapeutics Today
Is CRISPR Therapeutics AG (CRSP) the Worst ARK Stock to Buy According to Short Sellers?
Chardan Capital Maintains CRISPR Therapeutics(CRSP.US) With Buy Rating, Maintains Target Price $94
Evercore Maintains CRISPR Therapeutics(CRSP.US) With Hold Rating, Maintains Target Price $60
Crispr Therapeutics AG (CRSP) Gets a Hold From Evercore ISI
Analysts Are Bullish on Top Healthcare Stocks: Crispr Therapeutics AG (CRSP), Silence Therapeutics (SLN)